208 related articles for article (PubMed ID: 26365727)
1. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
Salgado P; Gilsanz F; Maseda E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
[TBL] [Abstract][Full Text] [Related]
2. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
5. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
7. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
[TBL] [Abstract][Full Text] [Related]
8. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
[TBL] [Abstract][Full Text] [Related]
10. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
11. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
12. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
13. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
14. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
15. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
[TBL] [Abstract][Full Text] [Related]
16. [Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Martínez JA
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():31-4. PubMed ID: 27608310
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-Resistant Enterobacteriaceae.
Iovleva A; Doi Y
Clin Lab Med; 2017 Jun; 37(2):303-315. PubMed ID: 28457352
[TBL] [Abstract][Full Text] [Related]
18. [ESBL and carbapenemases in Enterobacteriaceae].
Cherkaoui A; Emonet S; Renzi G; Riat A; Greub G; Schrenzel J
Rev Med Suisse; 2014 Nov; 10(450):2142-8. PubMed ID: 25549375
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria.
ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme
Euro Surveill; 2010 Nov; 15(46):. PubMed ID: 21144433
[No Abstract] [Full Text] [Related]
20. Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
Murray PR
MLO Med Lab Obs; 2013 May; 45(5):26, 28, 30. PubMed ID: 23763046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
